CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool.

Cell Mol Biol Lett · 2022 · PMC9066929 · PMID 35508982

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slightly increasing trendno p-value reported

In nude mice, LIN28B-AS1 KO HepG2 xenograft tumors had a slightly increasing trend compared with normal LIN28B-AS1-positive HepG2 xenograft tumors [ 106 ].

also in 801 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.